JD

Jitendrakumar Dayalal Thacker

Active Director Director DIN 11480787
DIN 11480787 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Jitendrakumar Dayalal Thacker

Data last updated:

Jitendrakumar Dayalal Thacker is a Director at Dishan India Pharma Private Limited (since 2026). The company operates in Healthcare.

DIN 11480787
Primary Designation Director
Industry Healthcare
First Appointment 13 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dishan India Pharma Private Limited U21002GJ2026PTC172029
Director13 Jan 20262026Active

Board colleagues of Jitendrakumar Dayalal Thacker

NameDINCompanyDesignation
Naresh Kantilal Pujara08454435Dishan India Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dishan India Pharma Private Limited
Premium access

Shareholding and investment profile for Jitendrakumar Dayalal Thacker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendrakumar Dayalal Thacker

Jitendrakumar Dayalal Thacker currently holds 1 directorship: Dishan India Pharma Private Limited (Director, since 13 Jan 2026).

Jitendrakumar Dayalal Thacker was first appointed on 13 Jan 2026 as Director at Dishan India Pharma Private Limited.

The current boards of Jitendrakumar Dayalal Thacker's companies include Naresh Kantilal Pujara (Dishan India Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available